The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance
Open accessAbstract
N -arachidonoylethanolamine (anandamide) was the first endogenous cannabinoid receptor ligand to be discovered. Dual synthetic pathways for anandamide have been proposed. One is the formation from free arachidonic acid and ethanolamine, and the other is the formation from N -arachidonoyl phosphatidylethanolamine (PE) through the action of a phosphodiesterase. These pathways, however, do not appear to be able to generate a large amount of anandamide, at least under physiological conditions. The generation of anandamide from free arachidonic acid and ethanolamine is catalyzed by a degrading enzyme anandamide amidohydrolase/fatty acid amide hydrolase operating in reverse and requires large amounts of substrates. As for the second pathway, arachidonic acids esterified at the 1-position of glycerophospholipids, which are mostly esterified at the 2-position, are utilized for the formation of N -arachidonoyl PE, a stored precursor form of anandamide. In fact, the actual levels of anandamide in various tissues are generally low except in a few cases. 2-Arachidonoylglycerol (2-AG) was the second endogenous cannabinoid receptor ligand to be discovered. 2-AG is a degradation product of arachidonic acid-containing glycerophospholipids such as inositol phospholipids. Several investigators have demonstrated that 2-AG is produced in a variety of tissues and cells upon stimulation. 2-AG acts as a full agonist at the cannabinoid receptors (CB1 and CB2). Evidence is gradually accumulating and indicates that 2-AG is the most efficacious endogenous natural ligand for the cannabinoid receptors. In this review, we summarize the tissue levels, biosynthesis, degradation and possible physiological significance of two endogenous cannabimimetic molecules, anandamide and 2-AG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–230 of 230
Sugiura, T., Yoshinaga, N., Kondo, S., Waku, K., & Ishima, Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2686 · Cited by 69
Self-citationMaccarrone, M., Bari, M., Menichelli, A., Giuliani, E., Principe, D. D., & Finazzi‐Agrò, A. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01942.x · Cited by 68
Microsomal cytochrome P450-mediated liver and brain anandamide metabolism
Bornheim, L. M., Kim, K. Y., Chen, B., & Correia, M. A. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00177-2 · Cited by 68
The endogenous cannabinoid receptor agonist anandamide impairs memory in rats
Mallet, P. E., & Beninger, R. J. (1996) · Behavioural Pharmacology · doi:10.1097/00008877-199605000-00008 · Cited by 67
Stefano, G. B., Bilfinger, T. V., Rialas, C. M., & Deutsch, D. G. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0702 · Cited by 64
Microsomal Synthesis of Fatty Acid Amides
Bachur, N. R., & Udenfriend, S. (1966) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96775-x · Cited by 63
Sugiura, T., Yoshinaga, N., & Waku, K. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01691-8 · Cited by 63
Self-citationBornheim, L. M., Kim, K. Y., Chen, B. L., & Correia, M. A. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2541 · Cited by 63
Simpson, C. M. F., Itabe, H., Reynolds, C., et al. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98494-2 · Cited by 62
Anandamide and other N-acylethanolamines in mouse peritoneal macrophages
Schmid, P. C., Kuwae, T., Krebsbach, R. J., & Schmid, H. H. O. (1997) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(97)00032-7 · Cited by 62
Yang, H.-Y. T., Karoum, F., Felder, C. C., Badger, H., Wang, T.-C. L., & Markey, S. P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721959.x · Cited by 61
CB1 Cannabinoid Receptor-Mediated Cell Migration
Song, Z.-H., & Zhong, M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39057-3 · Cited by 59
Distribution and characterization of anandamide amidohydrolase in mouse brain and liver
Watanabe, K., Ogi, H., Nakamura, S., Kayano, Y., Matsunaga, T., Yoshimura, H., & Yamamoto, I. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00052-6 · Cited by 56
Ueda, N., Liu, Q., & Yamanaka, K. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(01)00120-2 · Cited by 55
Katayama, K., Ueda, N., Katoh, I., & Yamamoto, S. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00124-9 · Cited by 55
Ueda, H., Kobayashi, T., Kishimoto, M., et al. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09829.x · Cited by 53
Ameri, A., & Simmet, T. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900200 · Cited by 51
Öz, M., Tchugunova, Y. B., & Dunn, S. M. J. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00396-4 · Cited by 51
Systemic and portal hemodynamic effects of anandamide
García, N., Járai, Z., Mirshahi, F., Kunos, G., & Sanyal, A. J. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.1.g14 · Cited by 47
Farooqui, A. A., Anderson, D. K., & Horrocks, L. A. (1993) · Brain Research · doi:10.1016/0006-8993(93)90366-u · Cited by 44
Biosynthesis and turnover of anandamide and other N‐acylethanolamines in peritoneal macrophages
Kuwae, T., Shiota, Y., Schmid, P. C., Krebsbach, R. J., & Schmid, H. H. O. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01226-0 · Cited by 41
Spinal anandamide inhibits nociceptive transmission via cannabinoid receptor activation in vivo
Harris, J. E., Drew, L., & Chapman, V. (2000) · Neuroreport · doi:10.1097/00001756-200008210-00041 · Cited by 40
Lysophosphoinositide-specific phospholipase C in rat brain synaptic plasma membranes
Tsutsumi, T., Kobayashi, T., Ueda, H., Yamauchi, E., Watanabe, S., & Okuyama, H. (1994) · Neurochemical Research · doi:10.1007/bf00967316 · Cited by 36
Enzymatic formation of fatty acid amides of ethanolamine by rat liver microsomes
Colodzin, M., Bachur, N. R., Weissbach, H., & Udenfriend, S. (1963) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(63)90044-5 · Cited by 34
Arai, Y., Fukushima, T., Shirao, M., Yang, X., & Imai, K. (2000) · Biomedical Chromatography · doi:10.1002/(sici)1099-0801(200004)14:2<118::aid-bmc936>3.0.co;2-o · Cited by 32
Cannabinoid Geometry and Biological Activity
Mechoulam, R., Devane, W. A., & Glaser, R. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_9 · Cited by 30
Arachidonic acid amide inhibitors of gap junction cell-cell communication
Boger, D. L., Sato, H., Lerner, A. E., Guan, X., & Gilula, N. B. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00148-1 · Cited by 30
Sasaki, T., & Chang, M. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00804-7 · Cited by 21
Huang, S., Strangman, N. M., & Walker, J. M. (1999) · PubMed · Cited by 16
Schrier, M. W. (1999) · 中国药理学报:英文版 · Cited by 15
Cited by
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners
Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306642200 · Cited by 805
Cannabinoid-based drugs as anti-inflammatory therapeutics
Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728
Neuronal Control of Skin Function: The Skin as a Neuroimmunoendocrine Organ
Roosterman, D., Goerge, T., Schneider, S. W., Bunnett, N. W., & Steinhoff, M. (2006) · Physiological Reviews · doi:10.1152/physrev.00026.2005 · Cited by 665
Heterosynaptic LTD of Hippocampal GABAergic Synapses
Chevaleyre, V., & Castillo, P. E. (2003) · Neuron · doi:10.1016/s0896-6273(03)00235-6 · Cited by 655
Metadata
- Authors
- Sugiura, T., Kobayashi, Y., Oka, S., & Waku, K.
- Venue
- Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA)
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 66
- Issue
- 2-3
- Pages
- 173-192
- ISSN
- 0952-3278 (ISSN-L)
- OpenAlex
- W2061306380
- Cited by
- 348
- References
- 230
- FWCI
- 16.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.